Recruiting Patients for Clinical Trials

ARC Rheumatologists are actively recruiting patients for clinical research studies in our office. All study-related expenses and medications will be provided at no expense to those patients who qualify. If you are interested in participating in any of the studies, please contact our ARC Rheumatology clinic coordinators at 512-344-0362 with eligibility questions or if you have further questions about clinical trial operations in general.

We are currently enrolling patients for clinical trials for the following disease states:


  • Cutaneous and Discoid Lupus

    • We are currently enrolling patients in an SCLE Study who:
      • Are between the age of 18-75 years old
      • Have SCLE and/or certain types of CLE for more than 6 months
      • Have active symptoms
  • Systemic Lupus Erythematosus (Lupus)

    • We are currently enrolling patients in an SLE Study who:
      • Have active SLE
      • Are between the ages of 18 and 75 years old
      • Are taking 1 or 2 SLE treatments
      • Are taking 20 mg/day of prednisone or equivalent, if on an oral corticosteroid
  • Psoriatic Arthritis

    • We are currently enrolling patients in the Apex Study who:
      • Are 18 years of age or older
      • Have had active psoriatic arthritis for at least 6 months
      • Have active plaque psoriasis
      • Have not responded to previous treatment for their condition
      • Have never received any biologic treatment for psoriatic arthritis or psoriasis
    • We are currently enrolling patients in the Star Study who have active psoriatic arthritis axial disease.
  • Ankylosing Spondylitis

    • We are currently enrolling patients with active Ankylosing Spondylitis into a clinical trial.
  • Sjogren’s Syndrome

    • We are currently enrolling patients with primary Sjogren’s Syndrome into a clinical trial.

If you are interested in participating in any of the studies, please contact our ARC Rheumatology clinic coordinators at 512-344-0362 with eligibility questions or if you have further questions about clinical trial operations in general.